Neonatal sepsis;Le sepsi neonatali

Recenti Progressi in Medicina

Volumn 92, Issue 11, 2001, Pages 690-695

  Lanari, Marcello ^a   Papa, Irene ^a   Venturi, Valentina ^a   Sermasi, Simona ^a   Corvaglia, Luigi ^a   Faldella, Giacomo ^a   Salvioli, Gian Paolo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cytokines; Newborn; Polimerase chain reaction; Prematurity; Sepsis

Indexed keywords

ACICLOVIR; ALBUMIN; AMINOGLYCOSIDE; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; BICARBONATE; CEPHALOSPORIN; CYTOKINE; DOBUTAMINE; DOPAMINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; INOTROPIC AGENT; INTERFERON; PLASMA PROTEIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; BREAST FEEDING; BREAST MILK; COAGULASE NEGATIVE STAPHYLOCOCCUS; CYTOKINE PRODUCTION; DEVELOPING COUNTRY; HUMAN; IMMUNOTHERAPY; INDUSTRIALIZATION; INTENSIVE CARE; ITALY; LOW BIRTH WEIGHT; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN SEPSIS; POLYMERASE CHAIN REACTION; PREMATURITY; REVIEW; RISK FACTOR; STREPTOCOCCUS AGALACTIAE;

HUMANS; INFANT, NEWBORN; SEPSIS;

EID: 0035214070     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. th ed Saunders 2001.
2. Bone RC, Balk RA, Cerra FB, et al. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The Consensus Conference Committee. American College for Chest Physician Society of Critical Care Medicine. Crit Care Med 1992; 20: 864-74.
3. Meadow W, Rudinsky B. Inflammatory mediators and neonatal sepsis. Clinics in Perinatology 1995; 22: 519-34.
4. Isaacs D. Prevention of early onset group B streptococcal infection: screen, treat, or observe? Arch Dis Child Fetal Neonatal Ed 1998; 79: F81-2.
5. Hickman ME, Rench MA, Ferrieri P, Baker CJ. Modificazioni nell'epidemiologia della colonizzazione da streptococci di gruppo B. Pediatrics ed it 1999; 2: 429-35.
6. Chirico G, Gasparoni A, Ciardelli L, Martinotti L, Viganò C, Rondini G. Le citochine in età neonatale. Riv Ital Pediatr (IJP) 1999; 25: 666-70.
7. Franz AR, Steinbach G, Kron M, Pohlandt F. Reduction of unnecessary antibiotic therapy in newborn infants using Interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics 1999; 104: 447-53.
8. Ng PC, Cheng SH, Chui KM, Fok TF, Wong MY, Wong W, Wong RPO, Cheung KL. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child 1997; 77: F221-7.
9. Arrieta A. Use of meropenem in the treatment of serious infections in children: review of the current literature . Clin Infect Dis 1997;24 (suppl 2):S207-12.
10. Hurst M, Lamb HM. Meropenem: a review of its use in patients in intensive care. Drugs 2000; 59: 653-80.
11. Stoll BJ, Gordon T, Korones SB, Shankaran S et al. Late-onset sepsis in very low birth weight neonates: a report fron: the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129 (1).
12. Villari P, Sarnataro C, Iacuzio L. Molecular Epidemiology of Szaphylococcus epidermidis in a Neonatal Intensive Care unit over a three-year period. J Clin Microbiol 2000; 38: 1740-6.
13. Cercenado E, Garcia-Leoni ME, Diaz D, Sanchez-Carrillo C, Catalan P et al. Emergence of teicoplanin-resistant coagulase-negative staphylococci. J Clin Microbiol 1996; 34: 1765-8.
14. Craft AP, Finer NN, Barrington KJ. Vancomycin for prophylaxis against sepsis in preterm neonates (Cochrane Review) In: The Cochrane Library 2000: 4.
15. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants (Cochrane Review). In: The Cochrane Library 2000: 4.
16. Modi N. Carr R. Promising stratagems for reducing the burden of neonatal sepsis. Arch Dis Child Fetal Neonatal 2000; 83: F150-3.
17. Rondini G, Chirico G. Hematopoietic growth factor levels in term and preterm infants. Curr Opin Hematol 1999; 6: 192-7.